Check Patient Eligibility
Patients may be appropriate for consideration if they:
- Are adults with a diagnosis of schizophrenia
- Have been newly prescribed or recently initiated treatment with TV-44749 within the past 30 days according to the approved local label
- Have at least 6 months of retrospective clinical data prior to treatment initiation
- Are able to provide written informed consent (from patient or authorized representative)
Patient may not be appropriate for consideration if they:
- Have an established diagnosis of treatment-resistant schizophrenia
- Have a prior non-response to TV-44749, per clinician’s judgement
- Have an established current diagnosis of HIV, cancers, liver failure, kidney failure, neuroleptic malignant syndrome, and diabetic ketoacidosis
- Have any medical or psychiatric condition that could jeopardize or would compromise the patient’s ability to participate in this study
- Are already participating in a clinical trial at the time of enrollment or within previous 6 months
Final determination for trial eligibility will be made by the site investigator.
See Official Trial Listing(s) for more information.
If you are interested in referring a patient, please Contact Teva Medical Affairs.